UNAUDITED COMPARATIVE FINANCIAL INFORMATION (Details) - USD ($) |
8 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Oct. 31, 2025 |
Oct. 31, 2024 |
|
| Unaudited Comparative Financial Information | ||||
| Revenues (includes sales to related parties of approximately $70,000, $88,000 and $199,000, respectively) | $ 5,868,000 | $ 3,098,000 | $ 5,199,000 | $ 4,620,000 |
| Cost of revenues | 1,128,000 | 566,000 | 931,000 | 844,000 |
| Gross profit | 4,740,000 | 2,532,000 | 4,268,000 | 3,776,000 |
| General and administrative expenses | 10,165,000 | 6,793,000 | ||
| Loss from operations | (5,425,000) | (4,261,000) | ||
| Other income (expense) | ||||
| Gain on sale of Exotropin interests | 390,000 | |||
| Interest expense | (27,000) | (58,000) | (98,000) | (92,000) |
| Change in obligation to repurchase shares | (3,000) | (5,000) | (2,000) | |
| Other income | 27,000 | 62,000 | 101,000 | 751,000 |
| Net loss | (5,038,000) | (4,262,000) | (5,521,000) | (4,705,000) |
| Net income attributable to the non-controlling interests | 36,000 | |||
| Net loss attributable to Zeo ScientifiX, Inc | $ (5,074,000) | $ (4,262,000) | $ (5,521,000) | $ (4,705,000) |
| Net loss per common share - basic | $ (0.68) | $ (0.67) | $ (0.86) | $ (0.74) |
| Net loss per common share - diluted | $ (0.68) | $ (0.67) | $ (0.86) | $ (0.74) |
| Weighted average number of common shares outstanding - basic | 7,493,536 | 6,356,800 | 6,409,953 | 6,336,392 |
| Weighted average number of common shares outstanding - diluted | 7,493,536 | 6,356,800 | 6,409,953 | 6,336,392 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|